When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.”

Please, watch this now before it’s too late.

CAPR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.00%

Insider Buying (Last 12 Months): $36,911.56

Insider Selling (Last 12 Months): $0.00

Capricor Therapeutics Insider Trading History Chart

Capricor Therapeutics Share Price & Price History

^$4.37

▼ -0.06 (-1.35%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Capricor Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/12/2023	David B Musket	Director	Buy	410	$2.75	$1,127.50	31,536
10/9/2023	David B Musket	Director	Buy	5,083	$2.82	$14,334.06	31,126
10/6/2023	Paul Gisbert Auwaerter	Director	Buy	5,000	$2.84	$14,200.00	5,000
10/4/2023	David B Musket	Director	Buy	2,500	$2.90	$7,250.00	26,043
3/28/2023	Xavier Avat	insider	Sell	3,000	$4.06	$12,180.00	14,772
7/6/2022	Xavier Avat	Insider	Buy	1,000	$3.68	$3,680.00	3,000
6/29/2022	David B Musket	Director	Sell	28,215	$3.77	$106,370.55	12,747
6/29/2022	Xavier Avat	Insider	Buy	1,500	$3.76	$5,640.00	2,000
6/27/2022	David B Musket	Director	Sell	17,775	$4.44	$78,921.00	40,962

Kiss of death from Joe Biden

From Porter & Company | Ad

I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.

I have uncovered a bombshell that changes everything… and threatens everything.

SEC Filings (Institutional Ownership Changes) for Capricor Therapeutics (NASDAQ:CAPR)

21.68% of Capricor Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Capricor Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	79,782	$0.38M	0.0%	+12.8%	0.249%
5/10/2024	Vanguard Group Inc.	1,365,903	$9.27M	0.0%	+17.2%	4.336%
5/1/2024	BNP Paribas Financial Markets	5,827	$40K	0.0%	N/A	0.018%
2/7/2024	Jump Financial LLC	52,800	$0.26M	0.0%	N/A	0.171%
12/6/2023	Citigroup Inc.	61,591	$0.21M	0.0%	N/A	0.200%
7/31/2023	LPL Financial LLC	78,436	$0.38M	0.0%	N/A	0.310%
5/1/2023	Virtu Financial LLC	16,895	$71K	0.0%	N/A	0.067%
11/7/2022	Jump Financial LLC	22,600	$0.14M	0.0%	N/A	0.093%
10/18/2022	Bailard Inc.	33,601	$0.20M	0.0%	+12.8%	0.138%
7/27/2022	Bailard Inc.	29,801	$0.10M	0.0%	N/A	0.123%
4/20/2022	Selective Wealth Management Inc.	213,494	$0.73M	0.3%	N/A	0.878%
11/16/2021	Two Sigma Securities LLC	11,511	$46K	0.0%	N/A	0.050%
11/15/2021	GSA Capital Partners LLP	96,632	$0.39M	0.0%	-14.0%	0.420%
11/15/2021	HighTower Advisors LLC	53,960	$0.22M	0.0%	+206.6%	0.234%
11/9/2021	Barclays PLC	6,330	$25K	0.0%	+246.1%	0.027%
11/9/2021	BlackRock Inc.	300,201	$1.21M	0.0%	-1.6%	1.304%
8/17/2021	Oracle Investment Management Inc.	1,166,249	$5.98M	0.8%	-41.7%	5.098%
8/16/2021	State Street Corp	71,748	$0.37M	0.0%	N/A	0.314%
8/13/2021	Northern Trust Corp	104,251	$0.54M	0.0%	+7.5%	0.456%
8/13/2021	Geode Capital Management LLC	184,990	$0.95M	0.0%	+7.9%	0.809%
8/13/2021	Vanguard Group Inc.	923,233	$4.74M	0.0%	+1.2%	4.035%
8/11/2021	Susquehanna Fundamental Investments LLC	16,500	$85K	0.0%	-49.1%	0.072%
8/5/2021	GSA Capital Partners LLP	112,364	$0.58M	0.1%	+684.6%	0.491%
5/18/2021	Millennium Management LLC	22,390	$0.11M	0.0%	-54.6%	0.098%
5/18/2021	Oracle Investment Management Inc.	1,999,464	$9.36M	1.4%	N/A	8.770%
5/12/2021	Northern Trust Corp	96,941	$0.45M	0.0%	-29.1%	0.425%
5/12/2021	M Holdings Securities Inc.	20,000	$94K	0.0%	N/A	0.088%
5/12/2021	Geode Capital Management LLC	171,415	$0.80M	0.0%	+40.7%	0.752%
5/10/2021	HighTower Advisors LLC	12,300	$57K	0.0%	-25.9%	0.054%
5/10/2021	GSA Capital Partners LLP	14,321	$67K	0.0%	-81.9%	0.063%
5/7/2021	BlackRock Inc.	347,103	$1.62M	0.0%	+1.2%	1.523%
5/3/2021	Trellus Management Company LLC	270,000	$1.26M	0.7%	N/A	1.184%
2/11/2021	Northern Trust Corp	136,814	$0.47M	0.0%	-9.6%	0.669%
2/9/2021	Bank of New York Mellon Corp	89,249	$0.31M	0.0%	+47.7%	0.436%
2/5/2021	BlackRock Inc.	343,011	$1.18M	0.0%	+0.4%	1.677%
2/4/2021	GSA Capital Partners LLP	79,091	$0.27M	0.0%	N/A	0.387%
11/17/2020	Jane Street Group LLC	12,943	$68K	0.0%	-51.1%	0.066%
11/13/2020	Morgan Stanley	44,843	$0.24M	0.0%	+26.4%	0.227%
11/12/2020	JPMorgan Chase & Co.	5,607	$30K	0.0%	+80,000.0%	0.028%
11/6/2020	BlackRock Inc.	341,523	$1.79M	0.0%	+900.8%	1.732%
9/15/2020	Two Sigma Advisers LP	21,130	$97K	0.0%	N/A	0.107%
8/17/2020	Jane Street Group LLC	26,474	$0.12M	0.0%	+9.6%	0.134%
8/12/2020	Goldman Sachs Group Inc.	38,808	$0.18M	0.0%	N/A	0.272%
8/10/2020	HighTower Advisors LLC	13,000	$59K	0.0%	N/A	0.091%
8/7/2020	Virtu Financial LLC	57,444	$0.26M	0.0%	N/A	0.403%

Data available starting January 2016

Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor’s lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.

Today's Range

Now: $4.37

$4.32

$4.56

50 Day Range

MA: $5.14

$4.40

$6.30

52 Week Range

Now: $4.37

$2.68

$8.22

Volume

275,692 shs

Average Volume

352,038 shs

Market Capitalization

$139.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of Capricor Therapeutics?: Capricor Therapeutics' top insider shareholders include:
David B Musket (Director)
Xavier Avat (Insider)
Paul Gisbert Auwaerter (Director)
Learn More about top insider investors at Capricor Therapeutics.
Who are the major institutional investors of Capricor Therapeutics?: Capricor Therapeutics' top institutional investors include:
Bank of New York Mellon Corp — 0.25%
Learn More about top institutional investors of Capricor Therapeutics stock.
Which major investors are buying Capricor Therapeutics stock?: Within the last quarter, CAPR stock was purchased by institutional investors including:
Bank of New York Mellon Corp
In the previous year, these company insiders have bought Capricor Therapeutics stock:
David B Musket (Director)
Xavier Avat (Insider)
Learn More investors buying Capricor Therapeutics stock.

Obama wins Presidential debate